Dr. Carolyn Y. Muller
Claim this profileUniversity of New Mexico Cancer Center
Studies Ovarian Cancer
Studies Endometrial Cancer
21 reported clinical trials
42 drugs studied
Area of expertise
1Ovarian Cancer
KRAS positive
NRAS positive
BRCA1 positive
2Endometrial Cancer
Stage IV
Stage I
Stage III
Affiliated Hospitals
Clinical Trials Carolyn Y. Muller is currently running
Ipatasertib + Megestrol Acetate
for Endometrial Cancer
This trial is testing if combining two drugs, ipatasertib and megestrol acetate, is more effective than using megestrol acetate alone for treating women with endometrial cancer that has returned or spread. Ipatasertib blocks enzymes needed for cancer cell growth, while megestrol acetate reduces and blocks estrogen, which some cancer cells need to grow.
Recruiting1 award Phase 1 & 2
Selumetinib + Olaparib
for Ovarian and Endometrial Cancer
This phase II ComboMATCH treatment trial compares selumetinib plus olaparib to selumetinib alone in women with endometrial or ovarian (fallopian tube and primary peritoneal) cancer that has come back (recurrent) or that remains despite treatment (persistent) and harbors a mutation in the RAS pathway. Selumetinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Olaparib is an inhibitor of PARP, an enzyme that helps repair deoxyribonucleic acid (DNA) when it becomes damaged. Blocking PARP may help keep tumor cells from repairing their damaged DNA, causing them to die. PARP inhibitors are a type of targeted therapy. The addition of olaparib to selumetinib could increase the percentage of tumors that shrink as well as lengthen the time that the tumors remain stable (without progression) as compared to selumetinib alone.
Recruiting1 award Phase 2
More about Carolyn Y. Muller
Clinical Trial Related1 year of experience running clinical trials · Led 21 trials as a Principal Investigator · 9 Active Clinical TrialsTreatments Carolyn Y. Muller has experience with
- Paclitaxel
- Pembrolizumab
- External Beam Radiation Therapy
- Cisplatin
- Quality-of-Life Assessment
- Questionnaire Administration
Breakdown of trials Carolyn Y. Muller has run
Ovarian Cancer
Endometrial Cancer
Skin Cancer
Relapse
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Carolyn Y. Muller specialize in?
Carolyn Y. Muller focuses on Ovarian Cancer and Endometrial Cancer. In particular, much of their work with Ovarian Cancer has involved KRAS positive patients, or patients who are NRAS positive.
Is Carolyn Y. Muller currently recruiting for clinical trials?
Yes, Carolyn Y. Muller is currently recruiting for 9 clinical trials in Albuquerque New Mexico. If you're interested in participating, you should apply.
Are there any treatments that Carolyn Y. Muller has studied deeply?
Yes, Carolyn Y. Muller has studied treatments such as Paclitaxel, Pembrolizumab, External Beam Radiation Therapy.
What is the best way to schedule an appointment with Carolyn Y. Muller?
Apply for one of the trials that Carolyn Y. Muller is conducting.
What is the office address of Carolyn Y. Muller?
The office of Carolyn Y. Muller is located at: University of New Mexico Cancer Center, Albuquerque, New Mexico 87106 United States. This is the address for their practice at the University of New Mexico Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.